HEADER MEMBRANE PROTEIN 13-APR-21 7MGW TITLE 5-HT BOUND SEROTONIN TRANSPORTER RECONSTITUTED IN LIPID NANODISC IN TITLE 2 NACL IN OCCLUDED CONFORMATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: SODIUM-DEPENDENT SEROTONIN TRANSPORTER; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: SERT, 5HT TRANSPORTER, 5HTT, SOLUTE CARRIER FAMILY 6 MEMBER COMPND 5 4; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: VARIABLE DOMAIN OF 15B8 ANTIBODY FAB HEAVY CHAIN; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: VARIABLE DOMAIN OF 15B8 ANTIBOTY FAB LIGHT CHAIN; COMPND 13 CHAIN: C; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SLC6A4, HTT, SERT; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 11 ORGANISM_COMMON: MOUSE; SOURCE 12 ORGANISM_TAXID: 10090; SOURCE 13 EXPRESSION_SYSTEM: MUS MUSCULUS; SOURCE 14 EXPRESSION_SYSTEM_COMMON: MOUSE; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 10090; SOURCE 16 MOL_ID: 3; SOURCE 17 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 18 ORGANISM_COMMON: MOUSE; SOURCE 19 ORGANISM_TAXID: 10090; SOURCE 20 EXPRESSION_SYSTEM: MUS MUSCULUS; SOURCE 21 EXPRESSION_SYSTEM_COMMON: MOUSE; SOURCE 22 EXPRESSION_SYSTEM_TAXID: 10090 KEYWDS HUMAN SEROTONIN TRANSPORTER, TRANSPORT, FAB, OCCLUDED, MEMBRANE KEYWDS 2 PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR D.YANG,E.GOUAUX REVDAT 1 15-DEC-21 7MGW 0 JRNL AUTH D.YANG,E.GOUAUX JRNL TITL ILLUMINATION OF SEROTONIN TRANSPORTER MECHANISM AND ROLE OF JRNL TITL 2 THE ALLOSTERIC SITE. JRNL REF SCI ADV V. 7 L3857 2021 JRNL REFN ESSN 2375-2548 JRNL PMID 34851672 JRNL DOI 10.1126/SCIADV.ABL3857 REMARK 2 REMARK 2 RESOLUTION. 3.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.500 REMARK 3 NUMBER OF PARTICLES : 114222 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING ONLY REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7MGW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-APR-21. REMARK 100 THE DEPOSITION ID IS D_1000255751. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : APO HUMAN SEROTONIN TRANSPORTER REMARK 245 IN COMPLEX WITH 15B8 FAB IN NACL REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 8.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5500.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CD1 ILE A 251 C9 D12 A 708 2.17 REMARK 500 CD1 ILE A 251 C11 D12 A 708 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 116 49.19 -83.49 REMARK 500 PRO A 120 45.86 -85.74 REMARK 500 ILE A 154 -61.45 -121.26 REMARK 500 PHE A 158 33.40 -97.15 REMARK 500 PRO A 196 47.65 -79.54 REMARK 500 GLU A 322 -50.82 -121.77 REMARK 500 ALA A 419 42.40 -109.08 REMARK 500 THR A 421 -8.39 73.11 REMARK 500 TRP A 535 -9.02 72.87 REMARK 500 PHE A 536 -55.80 -120.32 REMARK 500 ILE B 67 -61.05 -96.76 REMARK 500 ALA C 32 57.41 -91.06 REMARK 500 ALA C 75 13.49 59.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-23830 RELATED DB: EMDB REMARK 900 5-HT BOUND SEROTONIN TRANSPORTER RECONSTITUTED IN LIPID NANODISC IN REMARK 900 NACL IN OCCLUDED CONFORMATION DBREF 7MGW A 79 615 UNP P31645 SC6A4_HUMAN 79 615 DBREF 7MGW B 20 137 PDB 7MGW 7MGW 20 137 DBREF 7MGW C 21 130 PDB 7MGW 7MGW 21 130 SEQRES 1 A 537 ARG GLU THR TRP GLY LYS LYS VAL ASP PHE LEU LEU SER SEQRES 2 A 537 VAL ILE GLY TYR ALA VAL ASP LEU GLY ASN VAL TRP ARG SEQRES 3 A 537 PHE PRO TYR ILE CYS TYR GLN ASN GLY GLY GLY ALA PHE SEQRES 4 A 537 LEU LEU PRO TYR THR ILE MET ALA ILE PHE GLY GLY ILE SEQRES 5 A 537 PRO LEU PHE TYR MET GLU LEU ALA LEU GLY GLN TYR HIS SEQRES 6 A 537 ARG ASN GLY CYS ILE SER ILE TRP ARG LYS ILE CYS PRO SEQRES 7 A 537 ILE PHE LYS GLY ILE GLY TYR ALA ILE CYS ILE ILE ALA SEQRES 8 A 537 PHE TYR ILE ALA SER TYR TYR ASN THR ILE MET ALA TRP SEQRES 9 A 537 ALA LEU TYR TYR LEU ILE SER SER PHE THR ASP GLN LEU SEQRES 10 A 537 PRO TRP THR SER CYS LYS ASN SER TRP ASN THR GLY ASN SEQRES 11 A 537 CYS THR ASN TYR PHE SER GLU ASP ASN ILE THR TRP THR SEQRES 12 A 537 LEU HIS SER THR SER PRO ALA GLU GLU PHE TYR THR ARG SEQRES 13 A 537 HIS VAL LEU GLN ILE HIS ARG SER LYS GLY LEU GLN ASP SEQRES 14 A 537 LEU GLY GLY ILE SER TRP GLN LEU ALA LEU CYS ILE MET SEQRES 15 A 537 LEU ILE PHE THR VAL ILE TYR PHE SER ILE TRP LYS GLY SEQRES 16 A 537 VAL LYS THR SER GLY LYS VAL VAL TRP VAL THR ALA THR SEQRES 17 A 537 PHE PRO TYR ILE ILE LEU SER VAL LEU LEU VAL ARG GLY SEQRES 18 A 537 ALA THR LEU PRO GLY ALA TRP ARG GLY VAL LEU PHE TYR SEQRES 19 A 537 LEU LYS PRO ASN TRP GLN LYS LEU LEU GLU THR GLY VAL SEQRES 20 A 537 TRP ILE ASP ALA ALA ALA GLN ILE PHE PHE SER LEU GLY SEQRES 21 A 537 PRO GLY PHE GLY VAL LEU LEU ALA PHE ALA SER TYR ASN SEQRES 22 A 537 LYS PHE ASN ASN ASN CYS TYR GLN ASP ALA LEU VAL THR SEQRES 23 A 537 SER VAL VAL ASN CYS MET THR SER PHE VAL SER GLY PHE SEQRES 24 A 537 VAL ILE PHE THR VAL LEU GLY TYR MET ALA GLU MET ARG SEQRES 25 A 537 ASN GLU ASP VAL SER GLU VAL ALA LYS ASP ALA GLY PRO SEQRES 26 A 537 SER LEU LEU PHE ILE THR TYR ALA GLU ALA ILE ALA ASN SEQRES 27 A 537 MET PRO ALA SER THR PHE PHE ALA ILE ILE PHE PHE LEU SEQRES 28 A 537 MET LEU ILE THR LEU GLY LEU ASP SER THR PHE ALA GLY SEQRES 29 A 537 LEU GLU GLY VAL ILE THR ALA VAL LEU ASP GLU PHE PRO SEQRES 30 A 537 HIS VAL TRP ALA LYS ARG ARG GLU ARG PHE VAL LEU ALA SEQRES 31 A 537 VAL VAL ILE THR CYS PHE PHE GLY SER LEU VAL THR LEU SEQRES 32 A 537 THR PHE GLY GLY ALA TYR VAL VAL LYS LEU LEU GLU GLU SEQRES 33 A 537 TYR ALA THR GLY PRO ALA VAL LEU THR VAL ALA LEU ILE SEQRES 34 A 537 GLU ALA VAL ALA VAL SER TRP PHE TYR GLY ILE THR GLN SEQRES 35 A 537 PHE CYS ARG ASP VAL LYS GLU MET LEU GLY PHE SER PRO SEQRES 36 A 537 GLY TRP PHE TRP ARG ILE CYS TRP VAL ALA ILE SER PRO SEQRES 37 A 537 LEU PHE LEU LEU PHE ILE ILE CYS SER PHE LEU MET SER SEQRES 38 A 537 PRO PRO GLN LEU ARG LEU PHE GLN TYR ASN TYR PRO TYR SEQRES 39 A 537 TRP SER ILE ILE LEU GLY TYR CYS ILE GLY THR SER SER SEQRES 40 A 537 PHE ILE CYS ILE PRO THR TYR ILE ALA TYR ARG LEU ILE SEQRES 41 A 537 ILE THR PRO GLY THR PHE LYS GLU ARG ILE ILE LYS SER SEQRES 42 A 537 ILE THR PRO GLU SEQRES 1 B 118 GLN VAL GLN LEU GLN GLN SER GLY PRO GLU LEU VAL LYS SEQRES 2 B 118 LEU GLY ALA SER VAL ARG ILE SER CYS LYS ALA SER GLY SEQRES 3 B 118 TYR ARG PHE SER TYR SER TRP MET ASN TRP VAL LYS GLN SEQRES 4 B 118 ARG PRO GLY LYS GLY LEU GLU TRP ILE GLY ARG ILE TYR SEQRES 5 B 118 PRO GLY ASP GLY ASP THR LYS TYR SER GLY LYS PHE LYS SEQRES 6 B 118 GLY LYS ALA THR LEU THR ALA ASP LYS SER SER SER THR SEQRES 7 B 118 VAL TYR MET GLN LEU SER SER LEU THR SER GLU ASP SER SEQRES 8 B 118 ALA VAL TYR PHE CYS ALA ARG SER ALA TYR GLY SER GLU SEQRES 9 B 118 GLY PHE ALA MET ASP TYR TRP GLY GLN GLY THR SER VAL SEQRES 10 B 118 THR SEQRES 1 C 110 ASP ILE VAL LEU THR GLN SER PRO ALA SER LEU ALA VAL SEQRES 2 C 110 SER LEU GLY GLN ARG ALA THR ILE SER CYS ARG ALA SER SEQRES 3 C 110 GLU SER VAL ASP ASN TYR GLY ILE SER PHE LEU ASN TRP SEQRES 4 C 110 PHE GLN GLN LYS PRO GLY GLN PRO PRO LYS LEU LEU ILE SEQRES 5 C 110 TYR ALA ALA SER ASN GLN GLY SER GLY VAL PRO ALA ARG SEQRES 6 C 110 PHE SER GLY SER GLY SER GLY THR TYR PHE SER LEU ASN SEQRES 7 C 110 ILE HIS PRO MET GLU GLU ASP ASP THR ALA VAL TYR PHE SEQRES 8 C 110 CYS GLN GLN THR LYS GLY VAL SER TRP THR PHE GLY GLY SEQRES 9 C 110 GLY THR LYS VAL GLU ILE HET NAG D 1 14 HET NAG D 2 14 HET CL A 701 1 HET D12 A 702 12 HET LNK A 703 5 HET HP6 A 704 7 HET D12 A 705 12 HET D10 A 706 10 HET D12 A 707 12 HET D12 A 708 12 HET HP6 A 709 7 HET HP6 A 710 7 HET HP6 A 711 7 HET SRO A 712 13 HET HP6 A 713 7 HET HP6 A 714 7 HET SRO A 715 13 HET CLR A 716 28 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM CL CHLORIDE ION HETNAM D12 DODECANE HETNAM LNK PENTANE HETNAM HP6 HEPTANE HETNAM D10 DECANE HETNAM SRO SEROTONIN HETNAM CLR CHOLESTEROL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN SRO 3-(2-AMINOETHYL)-1H-INDOL-5-OL FORMUL 4 NAG 2(C8 H15 N O6) FORMUL 5 CL CL 1- FORMUL 6 D12 4(C12 H26) FORMUL 7 LNK C5 H12 FORMUL 8 HP6 6(C7 H16) FORMUL 10 D10 C10 H22 FORMUL 16 SRO 2(C10 H12 N2 O) FORMUL 20 CLR C27 H46 O HELIX 1 AA1 LYS A 84 VAL A 97 1 14 HELIX 2 AA2 ASP A 98 GLY A 113 1 16 HELIX 3 AA3 GLY A 114 PRO A 120 5 7 HELIX 4 AA4 TYR A 121 ARG A 144 1 24 HELIX 5 AA5 ILE A 148 ARG A 152 5 5 HELIX 6 AA6 CYS A 155 LYS A 159 5 5 HELIX 7 AA7 GLY A 160 SER A 190 1 31 HELIX 8 AA8 SER A 226 HIS A 235 1 10 HELIX 9 AA9 GLN A 238 SER A 242 5 5 HELIX 10 AB1 SER A 252 LYS A 272 1 21 HELIX 11 AB2 GLY A 273 THR A 284 1 12 HELIX 12 AB3 ALA A 285 ALA A 300 1 16 HELIX 13 AB4 TRP A 306 LEU A 313 1 8 HELIX 14 AB5 VAL A 325 GLY A 338 1 14 HELIX 15 AB6 GLY A 342 SER A 349 1 8 HELIX 16 AB7 ASN A 356 ASN A 391 1 36 HELIX 17 AB8 ASP A 393 VAL A 397 5 5 HELIX 18 AB9 PRO A 403 MET A 417 1 15 HELIX 19 AC1 PHE A 422 PHE A 454 1 33 HELIX 20 AC2 PHE A 454 ARG A 461 1 8 HELIX 21 AC3 ARG A 461 THR A 482 1 22 HELIX 22 AC4 GLY A 485 ALA A 496 1 12 HELIX 23 AC5 GLY A 498 TRP A 514 1 17 HELIX 24 AC6 GLY A 517 GLY A 530 1 14 HELIX 25 AC7 PHE A 536 TRP A 541 1 6 HELIX 26 AC8 ALA A 543 SER A 559 1 17 HELIX 27 AC9 PRO A 571 SER A 585 1 15 HELIX 28 AD1 ILE A 587 THR A 600 1 14 HELIX 29 AD2 THR A 603 ILE A 612 1 10 SHEET 1 AA1 4 GLN B 24 GLN B 25 0 SHEET 2 AA1 4 ARG B 38 LYS B 42 -1 O LYS B 42 N GLN B 24 SHEET 3 AA1 4 THR B 97 LEU B 102 -1 O MET B 100 N ILE B 39 SHEET 4 AA1 4 ALA B 87 ASP B 92 -1 N THR B 88 O GLN B 101 SHEET 1 AA2 6 GLU B 29 LEU B 30 0 SHEET 2 AA2 6 THR B 134 THR B 137 1 O THR B 137 N GLU B 29 SHEET 3 AA2 6 VAL B 112 TYR B 113 -1 N TYR B 113 O THR B 134 SHEET 4 AA2 6 MET B 53 GLN B 58 -1 N GLN B 58 O VAL B 112 SHEET 5 AA2 6 LEU B 64 ILE B 70 -1 O GLU B 65 N LYS B 57 SHEET 6 AA2 6 THR B 77 TYR B 79 -1 O LYS B 78 N ARG B 69 SHEET 1 AA3 5 GLU B 29 LEU B 30 0 SHEET 2 AA3 5 THR B 134 THR B 137 1 O THR B 137 N GLU B 29 SHEET 3 AA3 5 VAL B 112 TYR B 113 -1 N TYR B 113 O THR B 134 SHEET 4 AA3 5 MET B 53 GLN B 58 -1 N GLN B 58 O VAL B 112 SHEET 5 AA3 5 ALA B 116 ARG B 117 -1 O ALA B 116 N ASN B 54 SHEET 1 AA4 4 THR C 25 SER C 27 0 SHEET 2 AA4 4 ALA C 39 ARG C 44 -1 O ARG C 44 N THR C 25 SHEET 3 AA4 4 TYR C 94 ILE C 99 -1 O ILE C 99 N ALA C 39 SHEET 4 AA4 4 SER C 89 SER C 91 -1 N SER C 89 O SER C 96 SHEET 1 AA5 2 SER C 30 LEU C 31 0 SHEET 2 AA5 2 LYS C 127 VAL C 128 1 O LYS C 127 N LEU C 31 SHEET 1 AA6 2 ASP C 50 ASN C 51 0 SHEET 2 AA6 2 ILE C 54 SER C 55 -1 O ILE C 54 N ASN C 51 SHEET 1 AA7 5 ASN C 77 GLN C 78 0 SHEET 2 AA7 5 LYS C 69 TYR C 73 -1 N TYR C 73 O ASN C 77 SHEET 3 AA7 5 ASN C 58 GLN C 62 -1 N TRP C 59 O LEU C 71 SHEET 4 AA7 5 VAL C 109 GLN C 114 -1 O VAL C 109 N GLN C 62 SHEET 5 AA7 5 THR C 121 PHE C 122 -1 O THR C 121 N GLN C 114 SSBOND 1 CYS A 200 CYS A 209 1555 1555 2.03 SSBOND 2 CYS B 41 CYS B 115 1555 1555 2.03 SSBOND 3 CYS C 43 CYS C 112 1555 1555 2.03 LINK CD2 LEU A 89 C1 CLR A 716 1555 1555 1.49 LINK ND2 ASN A 208 C1 NAG D 1 1555 1555 1.44 LINK CD1 LEU A 248 C26 HP6 A 709 1555 1555 1.49 LINK CD1 ILE A 251 C10 D12 A 708 1555 1555 1.49 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.38 CISPEP 1 SER C 27 PRO C 28 0 -1.70 CISPEP 2 GLU C 47 SER C 48 0 8.84 CISPEP 3 GLY C 117 VAL C 118 0 -0.13 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000